Scholars Central

Editor-in-Chief

Angus Dalgleish

Professor of Oncology, Institute of Infection and Immunity, University of London, UK

About

As published by the journal they serve.

Professor Angus Dalgleish studied medicine at University College London where he obtained an MBBS and a BSc in Anatomy. He is a Fellow of The Royal College of Physicians of the UK and Australia, Royal College of Pathologists and The Academy of Medical Scientists. Currently he focussed on HIV pathogenesis and development of therapeutic vaccines. He is a co-founder of Onyvax, a company set up in 1998 to make novel vaccines for common solid tumours, where he is currently Research Director. He is the author or co-author of peer reviewed scientific papers and over 70 chapters in medical books. He is the co-editor of five medical books. He has been on numerous grant committees and is currently on the European Commission Cancer Board.

Research interests

  • Prof. Angus Dalgleish research interests includes HIV pathogenesis
  • Virus induced cancers and development of therapeutic vaccines

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

No article in our collection carries this name on its byline. Not every article names its authors in a way that can be matched, so this is not a list of everything they have written.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels